Safety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Recurrent Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms|Pancreatic Neoplasms
Interventions: DRUG: nab-Paclitaxel|DRUG: Nivolumab|DRUG: Gemcitabine|DRUG: Carboplatin
Sponsor: Celgene